Compliance Studio Resource Center

Most regulatory teams have a way of working that feels structured. There is an applicable list. Updates are tracked. Decisions are documented. The process fits the organisation, and over time it becomes accepted as “how we do regulatory.” From the inside, it looks like control. But when that same structure is tested outside the organisation — in an audit, an inspection, or a due diligence process — something changes. Questions that should have straightforward answers suddenly

Regulatory compliance is rarely where organisations fail. The real failure point is reconstructability. Most life science organisations already make regulatory decisions every day. The problem is not whether decisions exist, but whether those decisions can be reconstructed consistently, on demand and over time. This is where regulatory governance often starts to break down. In many organisations, regulatory reasoning is spread across emails, spreadsheets, documents, risk file

The development of Compliance Studio originated from a recurring observation in regulatory practice. Across more than 200 interviews with Regulatory Affairs and Quality Assurance professionals in medical devices, IVD, pharmaceuticals, and biotechnology, a consistent pattern emerged. The central challenge was not access to regulatory information, nor a lack of tools. Instead, it concerned the ability to determine and maintain a correct regulatory scope for a given product acro

Determining regulatory scope has always been a foundational task in Regulatory Affairs. It concerns which regulations apply to a given product, across which markets, and how that evolves over time. In practice, this has rarely been established as a stable construct. Instead, it is built and maintained through a combination of regulatory interpretation, internal documentation, and accumulated experience. This approach can function operationally. However, it introduces recurrin